The protein Daxx promotes Fas-mediated cell death through activation of apoptosis signal-regulating kinase 1, leading to the activation of the MAPKs JNK and p38. Owing to the in utero lethality of daxx-deficient mice, the in vivo role of Daxx has been so far difficult to analyze. We have generated transgenic mice expressing a dominant-negative form of Daxx (Daxx-DN) in the T-cell lineage. We show that Daxx is recruited to the Fas receptor upon FasL engagement and that Daxx-DN expression protects activated T cells from Fas-induced cell death, by preventing the death-inducing signal complex to be properly formed. Normal lymphocyte development and homeostasis are nevertheless observed. Interestingly, we report that both in vitro and in vivo stimulation of Daxx-DN T-lymphocytes leads to increased proliferative T-cell responses. This increased proliferation is associated with a marked increase in tyrosine phosphorylation of LAT and ZAP70 as Daxx-DN favor their recruitment to the T-cell receptor (TCR) complex. These findings identify Daxx as a critical regulator of T-lymphocyte homeostasis by decreasing TCRinduced cell proliferation and by promoting Fas-mediated cell death.
The tumor necrosis factor receptor (TNFR) superfamily members are cell-surface cytokine receptors controlling cell fate decisions, for example, proliferation, differentiation and cell death. 1 A prototype of the death receptor TNFR subfamily is Fas (CD95; APO-1). Fas-induced cell death has a critical role in both naturally and pathologically occurring cell death in several contexts including the development and the homeostasis of the immune and central nervous systems. 2 Upon engagement by its ligand (FasL), Fas rapidly recruits the adaptor molecule FADD to the membrane via a homologous death domain (DD) interaction. FADD then binds the caspase 8 proenzyme through an interaction with a homologous death effector domain (DED), leading to the formation of the death-inducing signal complex (DISC) 2 and proteolytic auto-activation of caspase 8. Mature caspase 8 then activates other caspases, which are presumed to execute the apoptotic dismantling of the cell. Among the substrates for caspase 8 is Bid, a proapoptotic member of the Bcl-2 family. Caspase 8-cleaved Bid targets mitochondria and induces cytochrome c release, thereby amplifying the death signal. 3 In addition to this classical FADD-dependent Fas pathway, in some transformed cells, a FADD-independent Daxx signalling pathway has been reported necessary for Fasmediated cell death. 4, 5 Daxx, an adaptor protein without a conventional DD, was first identified in a yeast two-hybrid screen through its ability to bind the DD of Fas via its Cterminal region, 4 independently of the binding of FADD to Fas. 6 In many cell lines, Daxx overexpression leads to an enhanced Fas-mediated apoptosis through a pathway sensitive to inhibition by Bcl-2, 4,7-9 although its role have been challenged by Villunger et al. 10 Interestingly, Daxx was also found localized in the nucleus, where it can associate directly with different DNA-binding transcription factors and functions as a transcriptional repressor. 11 It is notably recruited to the promyelocytic leukemia (PML) oncogenic domains interacting with the SUMO-1-modified PML. More recently, it was found that Daxx can modulate the function of mdm2 regulating therefore DNA damage-induced p53 activation. 12, 13 The importance of Fas and FasL in lymphocyte homeostasis and peripheral tolerance is revealed by the identification of mutations in their genes in both mice and humans where both lymphoproliferation and autoimmunity are observed. 14 Mice deficient in FADD, caspase 8 or FLIP (through either a germline deficiency or an overexpression of a dominant-negative form (DN) form) do not develop such pathological features, but present an unexpected defect in T-cell activation. [15] [16] [17] [18] As we recently demonstrated that Daxx and FADD pathways are both necessary for Fas-induced motoneuron death and operate in parallel, 19 we wished to investigate the physiological role of Daxx in T-cell homeostasis in vivo. Since targeted disruption of the daxx gene results in early embryonic lethality, 20 we chose to generate transgenic mice expressing, under the control of the lck promoter, a DN form of the mouse Daxx (Daxx-DN) protein. We show here that Daxx-DN transgenic peripheral T cells are not only resistant to Fas-mediated cell death but also more sensitive to T-cell receptor (TCR)-triggered proliferation in vivo.
Results
Generation of lck Daxx-DN transgenic (Daxx-DN Tg) mice. To inhibit the function of Daxx in vivo, we generated independent lines of transgenic mice expressing a mouse Daxx-DN (amino acids 628-739) fused to a FLAG tag under transcriptional control of the lck proximal promoter (Figure 1a ). This mutant contains only the Fas binding domain of Daxx, which mediates interaction of Daxx to the DD of Fas but lacks the apoptosis activation domain of Daxx (501-625), which is sufficient for the apoptotic activity of Daxx 4 ( Figure 1a) . Out of the four transgenic lines produced, one line, expressing the highest transgenic Daxx-DN, was chosen for further analysis.
Immunoblot revealed the presence of proteins corresponding to the expressed transgene in lysates from mature splenic T cells of Daxx-DN Tg mice (Figure 1b ). This expression was confirmed by staining of the transgene in permeabilized cells and found equivalent in peripheral CD4 and CD8 T cells (Figure 1c ).
Daxx-DN expression interferes with neither thymocyte development nor peripheral T-cell homeostasis. The Daxx-DN Tg mice appear healthy with normal cell counts for thymus, spleen and lymph nodes at 4-24 weeks of age (Supplementary Table 1 ). To identify a potential role for Daxx in thymocyte development or peripheral T-cell homeostasis, major thymocyte or mature T-cell subpopulations from Daxx-DN Tg mice and normal littermates control (NLC) mice were analyzed by flow cytometry for expression of different surface marker antigens. A normal representation populations and expression were found in thymus (data not shown) and in spleen or lymph nodes (Supplementary Figure 1) , suggesting that Daxx-DN expression does not have an apparent effect neither on thymocyte development nor on T-cell homeostasis.
Activated T cells from Daxx-DN Tg mice are protected against FasL-induced cell death. Primary T cells become sensitive toward FasL-induced apoptosis 3-5 days after activation. 21 Consistent with these data, we found that resting T cells were insensitive to killing by recombinant FasL, whereas activated T cells from control mice were rapidly killed after incubation with recombinant FasL (Figure 2a ). In contrast, T cells derived from Daxx-DN Tg mice were protected against FasL-induced cell death from day 3 following activation ( Figures 3a and b) , whereas no difference of the level of Fas expression at the cell surface of NLC and Daxx-DN T cells could be detected (data not shown). The extent of inhibition found is similar to that found in the presence of the caspase inhibitor Z-VAD or the (Figure 3b ). Thus, we concluded that the Daxx-DN expression prevents the DISC to be properly formed by preventing the recruitment of the endogenous Daxx protein to the DISC following Fas stimulation. Fas-mediated cell death assays and Fas immunoprecipitation experiments were also performed on L12.10.Fas T cells stably silenced for the Daxx expression (Daxx short hairpin RNA (shRNA)). Daxx was also recruited to the DISC in this cell line, and daxx knockdown resulted in an inhibition of Fasmediated cell death (Figure 2d and Supplementary Figure 3) , owing to the inhibition of the DISC formation (Figure 3c ).
In vitro activation-induced cell death (AICD) but not in vivo AICD is inhibited in Daxx-DN Tg T cells. We next examined the sensitivity of mature Daxx-DN Tg T cells to in vitro AICD. We found that preactivated splenic T cells from NLC mice were more sensitive to anti-CD3-induced cell death than Daxx-DN preactivated cells (Figure 4a ).
Daxx-DN Tg mice did not develop lymphadenopathy or age-dependent autoimmune disease typical for the lpr and gld T lymphocytes isolated from spleen of 6-to 10-week-old NLC, Daxx-DN Tg or FADD-DN Tg mice were purified and stimulated with 50 U/ml IL-2 plus coated antibody to CD3 at 1 mg/ml for 4 days (b and c) or for indicated times (a). The cells were then collected and plated at 1 Â 10 6 cells/ml for 4 h with 100 ng/ml FLAG-rhFASL plus 1 mg/ml anti-FLAG antibody (a and c), with titrated amounts of recombinant FasL plus 1 mg/ml anti-FLAG antibody (with or without Z-VAD, 10 mM) or with staurosporine (25 mM) (b). (c) Western blot analysis of total lysates of purified T splenocytes, activated for 4 days with coated anti-CD3 (1 mg/ml) plus IL-2 (50 U/ml) and then treated or not with 100 ng/ml FLAG-rhFASL plus 1 mg/ml anti-FLAG antibody for the indicated time. Blots were probed with anti- Figure 5a ). Therefore, whereas FADD-DN effectively blocked the proliferative response of T cells induced by anti-CD3 as previously reported, [22] [23] [24] Daxx-DN has an inverse effect by increasing T-cell proliferation. This effect could be clearly seen from day 3 of activation with peripheral T cells ( Figure 5b ). To better investigate the effect of the Daxx-DN transgene on proliferative response, we analyzed T-cell proliferation through in vitro 3 [H] thymidine incorporation assays. Activation-induced proliferation of Daxx-DN T cells was increased when compared with NLC T cells. Interestingly, this hyperproliferative behavior was even more pronounced when lower concentrations of anti-CD3 were used and cannot be observed after a PMA/ionomycin stimulation, indicating that the defect was probably close to the proximal events of the TCR signalling ( Figure 5c ).
To ensure that the increase in activation-induced expansion observed with Daxx-DN T cells was not simply the result of increased cell survival but was really a defect in cell cycling, we analyzed proliferation through carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling. The histograms obtained revealed the distribution of sequential cell divisions ( Figure 5d ). These data clearly confirmed that T cells from Daxx-DN mice proliferated more than those from NLC, whereas T cells from FADD-DN mice proliferated poorly (data not shown). ) isolated from NLC or Daxx-DN (Tg) mice and stimulated with 200 ng/ml FLAG-rhFasL plus 2 mg/ml M2 for 10 min or left unstimulated. Then Fas was immunoprecipitated as described in (a). (c) Fas immunoprecipitation was performed on L12.10 cells stably expressing short hairpin Daxx siRNA (shRNA Daxx) or control siRNA (shRNA control) after stimulation with 100 ng/ml FLAGrhFasL plus 2 mg/ml M2 for 3 min detectable whereas the CDKIs p21 and p19 expression is undetectable ( Figure 6 ). As expected, CD3 stimulation in NLC T cells leads to an induction of several key cyclins (cyclins A, E, D3) and CDKs (Cdk2, Cdk4, Cdk6), a decreased expression of the CDKIs p27, p15, p16, and a strong induction of CDKIs p21 and p19. Among all the cell cycle proteins examined, the induction of expression of the cyclins A, E, D3 and the CDKI p21 upon CD3 cross-linking was noticeably reduced in Daxx-DN T cells. The decreased expression of p21, a major pleiotropic inhibitor of several key CDKs, appears consistent with the increased proliferative status of the Daxx-DN T cells. In accordance with this observation, as the expression of p21 is regulated, in part, by the tumor suppressor gene p53, we found a dramatic To compare the proliferative ability of the TCR transgenic T cells (originated from OT1/wt or OT1/Daxx-DN ) in the absence or the presence of Daxx-DN, purified and CFSElabelled T splenocytes were transferred into congenic host mice followed by subcutaneous immunization with OVA and CFA adjuvant. Two days later draining lymph nodes were excised and T-cell proliferative responses were examined. Following an immunization with 10 mg OVA, 34.5% of OTI/ Daxx-DN T cells had already undergone at least four cycles (P4 þ P5) compared to only 23.7% of OTI/NLC T cells, thus corresponding to an increase of 32%. This increase is even more pronounced (53%) when the immunization was performed with 50 mg OVA (15.25% of OTI/NLC T cells in P4 þ P5 compared to 31.87% of OTI/Daxx-DN T cells) (Figure 7) .
We then concluded that antigen-stimulated OTI/Daxx-DN T cells proliferated more than their OTI counterparts, demonstrating that the Daxx-DN transgene affects antigen responsiveness in vivo.
Increased proliferative ability of Daxx-DN T cells is associated with an abnormal signal transduction downstream of the TCR. To study in greater details this increase in T-cell proliferation, we examined some early signalling events elicited upon TCR triggering. The activation status of the MAPK p38, JNK 1/2 and ERK1/2 was followed by analyzing their phosphorylation pattern (Figure 8a) . In contrast to NLC T cells, Daxx-DN T cells showed only a moderate p38 MAPK and JNK 1/2 activation after CD3 ligation, whereas ERK1/2 activation under the same conditions appeared to be increased.
Upon TCR engagement, the NFkB transcription factors family provides critical integration between signal transduction and transcription pathways activated in T cells. We therefore analyzed its activation in purified T cells by gel shift assays upon CD3 activation (Figure 8b ). We found a considerable increase of NFkB activation in Daxx-DN T cells Figure 2) . Interestingly, similar to what we observed for the Fas protein (Figure 3b) , the recruitment of Daxx to the TCR is decreased in the Daxx-DN T cells, whereas both the Daxx-DN and the phosphorylated ZAP70 proteins showed increased levels of TCR association (Figure 8d ) suggesting that following CD3 stimulation this truncated form of Daxx promoted the association of ZAP70 to the TCR membrane complex and thereby its phosphorylation.
Discussion
The importance of Daxx signalling in Fas-mediated cell death and peripheral T-cell deletion. The amount of peripheral T lymphocytes is strictly controlled through a delicate balance between the generation of T cells that emigrate from the thymus and the elimination of activated lymphocytes. We did not find any difference in the number or distribution of peripheral T-cell subpopulations in Daxx-DN Tg mice compared with NLC mice suggesting that Daxx is dispensable for T-cell homeostasis. However, we observed in anti-CD3-activated T cells a protection from Fas-mediated cell death provided by the overexpression of Daxx-DN, demonstrating the importance of Daxx in Fas-mediated cell death in this context. Whereas the presence of Fas was shown to be critical in the AICD of proliferating mature T cells in vitro, [26] [27] [28] the death of T cells activated in vivo was reported to be independent of the Fas/FasL system and, rather, required the presence of proapoptotic members of the Bcl2 family, for example, Bim, Bax or Bak. 29, 30 In this context, the data reported herein demonstrating that expression of Daxx-DN in T cells has no effect on in vivo AICD, is not really surprising. Similar effect has been described for both FLIP and FADD-DN overexpression 16, 18 and for caspase 8 deficiency. 17 In concert with the AICD results and, as found for all the above-mentioned genetically modified mice, Daxx-DN Tg mice do not accumulate aberrant T cells nor do the mice succumb to autoimmune diseases. These observations are consistent with the observation that Fas inactivation in T cells alone is insufficient for the pathogenesis of lymphoproliferative disease and that the development of such a syndrome requires the inactivation of Fas in both lymphoid and non-lymphoid tissues. 31 Upon FasL binding, Daxx is recruited to the DISC and promotes its formation. Although evidences for Daxx involvement in promoting Fas-mediated cell death appear clear from several studies, 11 Daxx was also reported dispensable for Fas-mediated cell death. 10 Additionally, antiapoptotic functions for Daxx were also reported for both Fas 32 and other cell death stimuli and contexts. 12, 20, 33, 34 More controversial issues were even raised when the binding of Daxx to Fas initially described failed to be reproduced and that the role of Daxx in Fas-mediated cell death was proposed to be initiated from the PML nuclear bodies. 5 We reported here in primary peripheral T cells that the endogenous Daxx protein is found within the DISC upon Fas stimulation. This recruitment is prevented by the overexpression of Daxx-DN, which decreases the ability of FADD and caspase 8 to be recruited to Fas. We then concluded that at least in T cells, Daxx possesses a critical role in Fas-mediated cell death to optimally form the DISC.
The effect of the absence of Daxx on T-cell proliferation and activation. Signalling molecules of the death receptor pathways, for example, FADD, c-FLIP or caspase 8, play also a critical role in the control of T-cell proliferation. 35 In this study, we have uncovered a novel role of Daxx in Tlymphocyte activation and proliferation. Daxx-DN expression results in an increased TCR-induced proliferation in T cells, accompanied by an abnormal signal transduction downstream of the TCR. In contrast to Daxx, the three main DISC components containing DED (FADD, caspase 8 and c-FLIP) are required to maintain homeostasis of peripheral T cells as positive regulators of T-cell proliferation. 36 No real mechanistic links have been yet defined to explain the role of these DED proteins in TCRinduced cell proliferation. Here, we show that the absence of Daxx substantially increases tyrosine phosphorylation of ZAP70 and LAT in response to activation through the TCR. Upon CD3 stimulation, the endogenous Daxx protein is rapidly recruited to the TCR and this recruitment is prevented by the overexpression of the Daxx-DN, which favors the association of ZAP70 to the TCR membrane complex and thereby its phosphorylation (Figure 8d ). We therefore propose that Daxx, by binding to the TCR complex upon CD3 stimulation (Figure 8d ) might limit the tyrosine phosphorylation of both LAT and ZAP70, two initial events in TCR activation cascade, and rather plays a role in TCR signalling pathways than in a cell cycle pathway.
Of note is that whereas the action of Daxx lies very close to the TCR activation at the membrane, the three others DED proteins belonging to the DISC, FADD, caspase 8 and FLIP, may collaborate further downstream of the TCR triggering probably by interacting with the CARMA complex. 37 Interestingly, although we cannot completely exclude an additional role for Daxx in transcriptional regulation, we demonstrate here that Daxx can also exert some of its functions by directly interacting with some receptors, independently of its role in transcriptional regulation and/or p53 activation/stability, as described in others contexts. 12, 13 Finally, it is likely that the role of Daxx in the regulation of cell proliferation is restricted neither to the T-cell compartment nor to the TCR-induced proliferation as: (i) a functional link of Daxx with a growth inhibitory effect has been recently reported upon CD40-mediated B-cell activation in vivo 38 as Daxxoverexpressing B lymphocytes stimulated with anti-CD40 antibodies proliferate less than their wild-type counterparts, thus revealing also a growth-suppressive function of Daxx in the B compartment and (ii) Daxx is found associated to TGF-b receptor II, 39 a receptor whose role in T-cell proliferation is critical in maintaining T-cell homeostasis and preventing lymphoproliferative disorder. 40 In conclusion, our results not only confirmed the essential proapoptotic role of Daxx in Fas-mediated cell death in vivo but also revealed a role of this protein in the regulation of TCRinduced proliferation of T cells by interfering in the very early proximal TCR pathway.
the murine lck promoter-FLAG/Daxx-DN transgene was injected into the male pronucleus of fertilized C57BL/6 animals. Resulting embryos were transferred into day 1-plugged pseudo-pregnant foster mice. Transgenic founders were identified by Southern blot analysis of DNA derived from tail snips. Heterozygous founder mice were backcrossed to C57BL/6 mice. Transgenic lines had no overt phenotype by observation and were maintained at heterozygosity and compared with NLC. The lck-FADD-DN mice were described previously. 24 To study AICD in vivo and antigen-induced proliferation in vivo, Daxx-DN Tg mice were crossed with Balb/c and OT-1 mice, 25 respectively. Peripheral T-cell isolation and purification. T-lymphocyte suspensions were prepared from spleen and inguinal lymph nodes from 6-to 10-week-old mice. Mature T cells were isolated from splenocytes using a mouse T-cell negative isolation kit according to the supplier's protocol (Dynal Biotech SA). Flow cytometry analysis (extracellular or intracellular staining). Cells (0.5-1 Â 10 6 ) were incubated with saturating amounts of conjugated antibodies for 30 min at 41C in PBS, 1% BSA (buffer F). After two washes in buffer F, streptavidin tri-color (Caltag) was added in the samples containing biotinylated antibodies. After 30 min incubation at 41C, cells were washed twice and analyzed. FLAG-tagged Daxx-DN expression was determined by cytoplasmic immunofluorescence staining. Cells were fixed for 15 min at room temperature in PBS, 1% paraformaldehyde and stained for 30 min on ice with 0.5 mg/ml mouse anti-FLAG (M5) monoclonal antibody in the presence of 1% BSA and 0.3% saponin (Sigma). Alexa Fluor-488-conjugated goat anti-mouse IgG (Fab 0 2-fragment) antibody (Molecular probes, Eugene, Oregon, USA) was used at 10 mg/ml as secondary reagent. Purified splenic T cells were stained with CFSE (Molecular Probes, Eugene, Oregon, USA) as described. 24 Staphylococcus enterotoxin-B-mediated T-cell deletion. Six-to 10-week-old NLC and Daxx-DN Tg mice were i.v.-injected with 100 mg SEB (1 mg/ml in PBS; Sigma Chemical Co., St Louis, MO, USA) and killed 3 or 8 days later to measure the amount of Vb8 þ and Vb6 þ T-cell expansion. Spleen and lymph node single cell suspensions were prepared and stained for cytometry analysis with anti-mVb8-FITC/anti-CD8-biot (Caltag) or anti-mVb8-FITC/anti-CD4-PE antibodies to detect T-cell expansion. As Vb6 is not deleted by SEB, anti-mVb6-FITC instead of anti-mVb8-FITC antibody was used as a control.
Fas and TCR activation procedures; Western blot analyses. For Fas activation, cells were collected, pre-warmed 4 min at 371C and stimulated with FLAG-rhFasL (0.1 mg/ml for T-cells and 0.025 mg/ml for L12.10) plus 1 mg/ml anti-FLAG antibody at 371C. For CD3 activation, cells were first pre-incubated at 371C for 5 min and then activated with anti-CD3 antibody (UCHT1, 20 mg/ml for T cells and 5 mg/ml for Jurkat). ) stimulated with 200 ng/ml (T cells) or 100 ng/ml (L12.10) FLAG-rhFasL plus 2 mg/ml M2 antibody for 5 min or left unstimulated at 371C. The post-nuclear supernatant (PNS) was prepared and solubilized in buffer A containing 0.5% Nonidet-P40 and 10% glycerol (lysis buffer) at 41C and then subjected to immunoprecipitation with biotinylated JO2 anti-Fas antibody coupled to streptavidin-agarose beads at 41C, overnight. The beads were washed four times with lysis buffer and the immunoprecipitates were eluted from beads by heating in Laemmli buffer at 951C for 5 min and subjected to SDS-PAGE, followed by immunoblotting with indicated antibodies.
TCR complex isolation was performed on T cells (2 Â 10 7 ) stimulated with 20 mg/ml anti-CD3e antibody (145.2c11) for 3 min or left unstimulated at 371C. The PNS was prepared and solubilized in buffer A containing 0.5% Nonidet-P40 and 10% glycerol (lysis buffer) at 41C and then subjected to immunoprecipitation with Protein A/G plus-agarose beads at 41C, overnight. Anti-CD3e antibody (145.2c11) was added to the unstimulated samples (1 mg/ml). The beads were washed four times with lysis buffer and the immunoprecipitates were eluted from beads by heating in Laemmli buffer at 951C for 5 min and subjected to SDS-PAGE, followed by immunoblotting with indicated antibodies.
Cell death experiments. Cell death experiments on purified T cells were performed after CD3 activation: briefly, cells (2 Â 10 6 cells/well, 24-well plate) were stimulated with plate-bound anti-CD3 antibody (1 mg/ml), in the presence of recombinant mouse IL-2 (50 U/ml) for 4 days. The cells were then collected and either plated at 10 6 cells/ml for 4 h for killing assay with FLAG-rhFasL/anti-FLAG antibody or with staurosporine, or for in vitro AICD, washed, put back into culture in the presence of IL-2 (50 U/ml) for 2 more days, before being restimulated with platebound CD3 MAb (1 mg/ml) for 24 h.
L12.10 cells were washed twice with serum-free medium, distributed at 1 Â 10 6 cells/ml and treated with FLAG-rhFasL/anti-FLAG antibody for 4 h. Cell death was determined by propidium iodide (PI) staining on fixed cells as described previously. 24 In vitro proliferation analysis. 3 [H] thymidine incorporation assay were performed as described by Zörnig et al.
24
T-cell adoptive transfer and immunizations. CFSE-labelled purified T cells (6 Â 10 6 cells) from Daxx-DN Â OT-1 mice were transferred through an i.v. injection into congenic recipient mice. Mice were immunized subcutaneously 24 h post-transfer with 10 or 50 mg of OVA (Sigma-Aldrich) emulsified in CFA (SigmaAldrich). Two days post-injection, mice were killed and lymph nodes were removed. Single-cell suspensions were surface-stained with PE-labelled anti-Va2 and biotinlabelled anti-CD8. Proliferation of TCR Tg T cells was determined by the CFSE profile analysis within the CD8 þ Va2 þ T-cell subset.
Electrophoretic mobility shift assay (EMSA). EMSA were performed as described previously. 41 
